In many cases, a tumor’s progression can be the difference between life and death. How does this happen and what can be done to help save lives? Join us for a live, interactive webinar with American Cancer Society Research Professor Yibin Kang, PhD, and Philanthropy Director — and metastatic breast cancer patient — Rachel Fournier as they discuss new insights and therapies for metastatic breast cancer
Dr. Susanna Greer
Director of Clinical Cancer Research, Nutrition, and Immunology
American Cancer Society
Dr. Susanna Greer joined the American Cancer Society (ACS) as Scientific Director of Clinical Cancer Research and Immunology in 2015. Dr. Greer received her Ph.D. Immunology from the University of Alabama at Birmingham, was a postdoctoral fellow at the Lineberger Comprehensive Cancer Center at the University of North Carolina and was recruited to Georgia State University as a Georgia Cancer Coalition Distinguished Cancer Scholar. To support scientists in developing skills in outreach and communication, Dr. Greer collaborated with the American Society of Biochemistry and Microbiology to develop the internationally offered course, The Art of Science Communication; served as a science communication consultant, and is the co-host of the ACS Research podcast, TheoryLab.
Dr. Yibin Kang
American Cancer Research Professor and Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University
Dr. Yibin Kang is a Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University and an Associate Director of Rutgers Cancer Institute of New Jersey. He graduated with a bachelor’s degree from Fudan University in Shanghai in 1995. After completing his graduate study at Duke in 2000, Dr. Kang became an Irvington Institute postdoctoral fellow with Dr. Joan Massagué at the Memorial Sloan-Kettering Cancer Center and pioneered a functional genomic approach to elucidate mechanism of breast cancer metastasis. Dr. Kang joined the faculty of Princeton University as an Assistant Professor of Molecular Biology in 2004. He was promoted to Associate Professor with tenure in 2010 and to Endowed Chair Full Professor in 2012. Dr. Kang’s research focuses on the molecular mechanisms of breast cancer metastasis. His work discovered new genes that promote recurrence, metastasis and chemoresistance of breast cancer, delineated tumor-stromal interactions that are essential for metastatic growth, and identified novel regulators with dual functions in mammary gland cell fate determination and tumor progression.
Philanthropy Director – Foundation Relations
American Cancer Society
Rachel was diagnosed with de novo metastatic breast cancer in 2015 at the age of 38 with no family history of cancer. She has advocated for funding for cancer research at the federal level and served as a patient advisor for the development of several new breast cancer drugs. She has participated on many conference panels to share her experience of living joyfully with cancer and counsels newly diagnosed metastatic patients. Rachel joined ACS in February 2020. As Director of Foundation Relations for the Northeast Region, she hopes to do her part in advancing cancer research and providing access to care for those most in need.Rachel lives in Cherry Hill, New Jersey with her husband, Keith, teenaged daughter and son, and a rescue dog.